Skip to content
YaoPharma
-
Pfizer strengthens obesity drug pipeline with USD2B licensing deal with YaoPharma
YaoPharma stands to earn as much as USD1.94 billion in additional milestone payments tied to development, regulatory, and commercial achievements.